Vertical AI Capital Trajectory H2 2026
.jpg)
Vertical AI absorbed the largest share of growth-stage venture capital in 2025, and that concentration continued into 2026. PitchBook recorded 2,847 vertical AI deals in 2025, with Series B and C rounds deploying $42.3 billion in capital. Median Series B pricing reached 11.8x trailing ARR against a broader software median of 6.2x. Beneath the headlines, the category is bifurcating: top-decile companies are raising at 14-18x ARR in three-week processes with pre-emptive term sheets, while the bottom three quartiles are raising at 4-6x ARR through 19-week processes when they raise at all.
The drivers are structural. Dry powder concentration in growth equity has reached 68 percent in the top quartile of funds, against 47 percent five years ago. Strategic acquirers completed 412 vertical AI transactions in 2025 against 187 in 2023, with 25 corporate acquirers accounting for 73 percent of aggregate deal value. The practical buyer universe for a growth-stage round has narrowed to roughly 40 active growth equity funds and 25 strategic acquirers, and most founders are misreading that buyer set.
This report sets out three findings. First, multiple compression in vertical AI is not uniform; it is sorting. Second, the buyer set has narrowed materially and founders running broad outreach are forfeiting leverage. Third, founders raising successfully in H2 2026 are running tighter processes against shorter buyer lists with better diligence preparation, not longer processes against broader lists. Section 6 lays out the framework Yanne Capital applies across vertical AI advisory mandates, and Section 10 sets out the specific market conditions we expect through Q1 2027.
- Vertical AI growth-stage rounds (Series B and C) deployed $42.3 billion in 2025, up from $34.1 billion in 2024 (Source: PitchBook US Venture Deal Terms, Q1 2026).
- Median Series B trailing ARR multiple compressed from 13.4x in H1 2024 to 10.6x in Q1 2026, but top-decile companies still priced at 16.2x while bottom-quartile compressed to 4.8x (Source: PitchBook US Venture Deal Terms, Q1 2026).
- The top 40 funds account for 71 percent of capital deployed into vertical AI growth-stage rounds, against 54 percent in 2019 and 61 percent in 2022 (Source: PitchBook US Venture Deal Terms, Q1 2026).
- Strategic acquisitions of vertical AI companies reached 412 transactions in 2025 against 187 in 2023, with 25 corporate acquirers accounting for 73 percent of aggregate deal value (Source: Bloomberg ECM and M&A database, January 2026).
- Growth-stage debt deployment into vertical AI reached $8.4 billion in 2025, against $2.7 billion in 2023 (Source: PitchBook US Venture Deal Terms, Q1 2026).
- Healthcare workflow AI commanded the highest sub-category pricing at 14.2x trailing ARR, while industrial and supply chain AI priced at 8.9x (Source: PitchBook US Venture Deal Terms, Q1 2026).
FAQ
What is the median ARR multiple for vertical AI Series B rounds in 2026?
The aggregate median trailing ARR multiple for vertical AI Series B rounds was 10.6x in Q1 2026, compressed from 13.4x in H1 2024 (PitchBook US Venture Deal Terms, Q1 2026). The aggregate is misleading: top-decile companies raised at a median 16.2x while bottom-quartile companies raised at 4.8x. Pricing is now predicted by position within the operating distribution rather than by sector membership.
How concentrated is the buyer universe for vertical AI growth-stage rounds?
Of 412 funds that participated in at least one vertical AI Series B or C round in 2025, the top 40 funds accounted for 71 percent of capital deployed (PitchBook, Q1 2026). The practical addressable buyer universe is closer to 40 active leads and 60-80 follow-on participants. Strategic capital is similarly concentrated, with 25 corporate acquirers accounting for 73 percent of strategic transaction value in 2025.
How long is a typical vertical AI Series B process taking in 2026?
Process duration has bifurcated. Top-decile companies are running 21-30 day processes, with 31 percent of priced rounds closing on pre-emptive terms in Q1 2026 (Cooley GO, Q1 2026 Venture Financing Report). Bottom-quartile companies are running 90-130 day processes with median 47 outreach contacts. Yanne Capital advisory mandates produced a median process duration of 39 days in 2025-2026 against an aggregate market median of 71 days.
Which vertical AI sub-categories are commanding the highest multiples?
Median Series B trailing ARR multiples by sub-category are: healthcare workflow AI 14.2x, defense and dual-use AI 13.6x, financial services AI 10.4x, legal and compliance AI 9.8x, and industrial and supply chain AI 8.9x (PitchBook, Q1 2026). The healthcare workflow premium reflects median net revenue retention of 121 percent and clear contracting paths into Epic, Cerner, and major payer infrastructure.
Who is Yanne Capital?
Yanne Capital is an SEC-registered boutique investment bank advising growth-stage companies on equity, debt, and M&A transactions across 26 sectors, with 240+ closed deals and relationships with 3,500+ institutional investors globally.
Discuss this with our team
If you are a founder running a vertical AI growth round in the next nine months, or evaluating the trade-off between an equity round and a strategic process, Yanne Capital can provide a confidential review of your positioning, buyer list, and process design grounded in the same framework applied across our advisory mandates. Reach out to us.